Page 1 | Search Results | Journal of Experimental Medicine | Rockefeller University Press

Skip to Main Content

Skip Nav Destination

1-3 of 3

Sort by

Sort Order Select

Journal Articles

APOBEC3A catalyzes mutation and drives carcinogenesis in vivo

Emily K. Law, Rena Levin-Klein, Matthew C. Jarvis, Hyoung Kim, Prokopios P. Argyris, Michael A. Carpenter, Gabriel J. Starrett, Nuri A. Temiz, Lindsay K. Larson, Cameron Durfee, Michael B. Burns, Rachel I. Vogel, Spyridon Stavrou, Alexya N. Aguilera, Sandra Wagner, David A. Largaespada, Timothy K. Starr, Susan R. Ross, Reuben S. Harris

J Exp Med (2020) 217 (12): e20200261.

https://doi.org/10.1084/jem.20200261

Published: 01 September 2020

View article titled, APOBEC3A catalyzes mutation and drives carcinogenesis in vivo

Journal Articles

Haploinsufficiency for Tumor Suppression: The Hazards of Being Single and Living a Long Time

David A. Largaespada

J Exp Med (2001) 193 (4): F15–F18.

https://doi.org/10.1084/jem.193.4.F15

Published: 20 February 2001

View article titled, Haploinsufficiency for Tumor Suppression: The Hazards of Being Single and Living a Long Time

Journal Articles

Cloning of the Murine Thymic Stromal Lymphopoietin (Tslp) Receptor: Formation of a Functional Heteromeric Complex Requires Interleukin 7 Receptor

Linda S. Park, Unja Martin, Kirsten Garka, Brian Gliniak, James P. Di Santo, Werner Muller, David A. Largaespada, Neal G. Copeland, Nancy A. Jenkins, Andrew G. Farr, Steven F. Ziegler, Philip J. Morrissey, Raymond Paxton, John E. Sims

J Exp Med (2000) 192 (5): 659–670.

https://doi.org/10.1084/jem.192.5.659

Published: 28 August 2000

View article titled, Cloning of the Murine Thymic Stromal Lymphopoietin (Tslp) Receptor: Formation of a Functional Heteromeric Complex Requires Interleukin 7 Receptor